A Conversation with Dr. Pashtoon Kasi
August 17, 2022
Dr. Pashtoon Kasi is the Englander Institute for Precision Medicine’s Director for Liquid Biopsy Research. He is an oncologist and researcher focused on treating patients with gastrointestinal cancers and other solid tumors using novel clinical trials and therapies. His focus has been on understanding the genomics and genetics of the underlying cancer, and to help treat these cancers in a more personalized fashion.
Novel Technique Provides Insights into Lung Pathology in COVID-19
August 4, 2022
Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases. In the study, published in the May 2021 issue of Nature, the researchers imaged autopsied lung tissue in a way that simultaneously highlighted dozens of molecular markers on cells.
Using Circulating Tumor DNA in Colorectal Cancer
July 28, 2022
Our Director for Liquid Biopsy Research, Pashtoon Kasi, M.D., recently published an article, “Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices,” in the Journal of Clinical Oncology that is attracting a lot of attention.
The paper’s abstract is listed below, and you can find the full article by following this link.
EIPM's 2Q External Newsletter
July 14, 2022
Summer 2022
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our second quarterly newsletter of 2022!
A Conversation with Grace Le
July 11, 2022
We are pleased to introduce Grace Le, a student at Cornell Tech who spent several months at the beginning of the year working with our colleague Alex Sigaras, M.S., Assistant Professor of Research in Physiology and Biophysics, and director of the EIPM AI-XR Lab. We hope you enjoy learning more about her background and research interests.
Please tell our readers a little bit about yourself.
Mantle Cell Lymphoma Treatment Varies According to Setting
July 5, 2022
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators from Weill Cornell Medicine and other leading health institutions.
New Technology Helps Reveal Inner Workings of Human Genome
June 23, 2022
Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional structure of the human genome, or how the genome folds. The genome is the complete set of genetic instructions, DNA or RNA, enabling an organism to function.
June 2022 EIPM Director's Memo
June 6, 2022
Dear Members of the Englander Institute,
I really enjoy talking to people about the exciting work happening at the EIPM, it can lead to all kinds of collaborations, professional opportunities, and new sources of support.